Using robust scientific and lay review, in the 2023 cycle, the GI Research Foundation awarded $550,000 to six investigators at the University of Chicago for novel research projects.
David T. Rubin, MD, the GI Research Foundation’s senior scientific advisor and Chief of the Section of Gastroenterology, Hepatology and Nutrition at UChicago Medicine said, “This year’s competitive grant awards support science that will advance treatment of inflammatory bowel disease (IBD), help prevent colon cancer recurrence, help better understand the gut microbiome and will advance work in regenerative medicine, a burgeoning area of research in the treatment and cure of IBD.”
- Cambrian Liu, PhD: Reprogramming stem cells to heal inflammation ($100,000)
- David T. Rubin, MD and Ashley Sidebottom, PhD: Understanding the role of gut inflammation as a cause of anxiety and depression in IBD ($100,000)
- Benjamin Shogan, MD and Tao Pan, PhD: How tumor genetics and diet impact colorectal cancer recurrence ($100,000)
- Bozhi Tian, PhD and Jiping Yue, MD: Optimizing the gut environment for better health ($100,000)
- Yanchun Li, PhD: How targeting cell aging could open new treatments for IBD ($100,000)
- Valerie Abadie, PhD: Loss of tolerance to commensal microbiota in the context of celiac disease: implications for disease development and progression ($50,000)